Dalfampridine as a promising agent in the management of hereditary spastic paraplegia: A triple-blinded, randomized, placebo-controlled pilot trial

Hereditary Spastic Paraplegia: An Update

(2022) Arun Meyyazhagan et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Hereditary spastic paraparesis: The real-world experience from a Neurogenetics outpatient clinic

(2022) Inês A. Cunha et al.   European Journal of Medical Genetics

The Puzzle of Hereditary Spastic Paraplegia: From Epidemiology to Treatment

(2022) Arun Meyyazhagan et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia — The SPASTOX Trial

(2021) Fabricio Diniz de Lima et al.   MOVEMENT DISORDERS

Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials

(2021) Enyao Zhang et al.   Orphanet Journal of Rare Diseases

Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature

(2019) Marta Bellofatto et al.   Frontiers in Neurology

Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches

(2019) Samuel Shribman et al.   LANCET NEUROLOGY

Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks

(2016) Paulo Victor Sgobbi de Souza et al.   CEREBELLUM

The Effects of Dalfampridine on Hereditary Spastic Paraparesis

(2016) Ugur Uygunoglu et al.   EUROPEAN NEUROLOGY

Improved Gait Performance in a Patient With Hereditary Spastic Paraplegia After a Continuous Intrathecal Baclofen Test Infusion and Subsequent Pump Implantation: A Case Report

(2015) Herre W. Heetla et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Dalfampridine in hereditary spastic paraplegia: a prospective, open study

(2015) Matthieu Béreau et al.   JOURNAL OF NEUROLOGY

Robot-Assisted Gait Training in a Patient With Hereditary Spastic Paraplegia

(2015) Han Gil Seo et al.   PM&R

Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia

(2014) Konstantinos Margetis et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Hereditary spastic paraplegia: Clinical-genetic characteristics and evolving molecular mechanisms

(2014) Temistocle Lo Giudice et al.   EXPERIMENTAL NEUROLOGY

The effect of hydrotherapy treatment on gait characteristics of hereditary spastic paraparesis patients

(2014) Yanxin Zhang et al.   GAIT & POSTURE

Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis

(2011) Craig I. Coleman et al.   CURRENT MEDICAL RESEARCH AND OPINION

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

(2010) Andrew D. Goodman et al.   ANNALS OF NEUROLOGY